Literature DB >> 18650328

Amphetamine exposure enhances accumbal responses to reward-predictive stimuli in a pavlovian conditioned approach task.

Xun Wan1, Laura L Peoples.   

Abstract

Acute and repeated exposure to psychostimulants such as amphetamine enhances the effects of pavlovian conditioned stimuli on conditioned behavior. It is hypothesized that amphetamine facilitates conditioned stimulus (CS) effects by selectively enhancing accumbal neuronal responses to stimuli. To test this hypothesis, rats were trained to discriminate between two pavlovian stimuli. One stimulus (i.e., CS+) was paired with sucrose delivery [i.e., unconditioned stimulus (US)], and the other stimulus (i.e., CS-) was paired with the absence of sucrose. Animals developed a conditioned approach response that occurred during the CS+ but not during the CS-. We tested the effect of different doses of amphetamine (0, 0.25, 0.5, or 1.0 mg/kg) on this conditioned approach behavior as well as on accumbal neuronal responses time locked to the CS+, the CS-, and the US. Acute amphetamine exposure increased conditioned approach behavior during the CS+, but not during the CS-. This change in behavior was associated with a selective increase in the magnitude of accumbal responses during the CS+. Repeated amphetamine administration followed by a drug-free period and reexposure did not affect the conditioned behavior, but increased accumbal responses to the CS+. These findings support the hypothesis that amphetamine exposure enhances behavioral responses to pavlovian conditioned stimuli by amplifying accumbal responses to those stimuli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650328      PMCID: PMC6670845          DOI: 10.1523/JNEUROSCI.1071-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence.

Authors:  Emily R Hankosky; Joshua M Gulley
Journal:  Dev Psychobiol       Date:  2012-07-06       Impact factor: 3.038

2.  Putative γ-aminobutyric acid neurons in the ventral tegmental area have a similar pattern of plasticity as dopamine neurons during appetitive and aversive learning.

Authors:  Yun-Bok Kim; Marguerite Matthews; Bita Moghaddam
Journal:  Eur J Neurosci       Date:  2010-11       Impact factor: 3.386

3.  Disentangling pleasure from incentive salience and learning signals in brain reward circuitry.

Authors:  Kyle S Smith; Kent C Berridge; J Wayne Aldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

4.  Amphetamine exposure selectively enhances hippocampus-dependent spatial learning and attenuates amygdala-dependent cue learning.

Authors:  Rutsuko Ito; Melissa Canseliet
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

5.  Amphetamine-induced enhancement of responding for conditioned reward in rats: interactions with repeated testing.

Authors:  Todor V Gerdjikov; Tyson W Baker; Richard J Beninger
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

6.  The effects of amphetamine sensitization on conditioned inhibition during a Pavlovian-instrumental transfer task in rats.

Authors:  Michael W Shiflett; Meaghan Riccie; RoseMarie DiMatteo
Journal:  Psychopharmacology (Berl)       Date:  2013-05-29       Impact factor: 4.530

7.  Effects of acute amphetamine exposure on two kinds of Pavlovian approach behavior.

Authors:  John Michael Holden; Laura L Peoples
Journal:  Behav Brain Res       Date:  2009-11-13       Impact factor: 3.332

8.  Acute effects of nicotine amplify accumbal neural responses during nicotine-taking behavior and nicotine-paired environmental cues.

Authors:  Karine Guillem; Laura L Peoples
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

9.  Amphetamine disrupts haemodynamic correlates of prediction errors in nucleus accumbens and orbitofrontal cortex.

Authors:  Emilie Werlen; Soon-Lim Shin; Francois Gastambide; Jennifer Francois; Mark D Tricklebank; Hugh M Marston; John R Huxter; Gary Gilmour; Mark E Walton
Journal:  Neuropsychopharmacology       Date:  2019-11-08       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.